Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - Ace Over Expression in Mice Targeted Metabolomics Study

ABSTRACT: Over-expression of angiotensin converting enzyme in mouse neutrophils and macrophages producing phenotypic changes in metabolism.

INSTRUMENT(S): Agilent 6470A Triple Quadrupole

ORGANISM(S): Mus Musculus (ncbitaxon:10090)

SUBMITTER: Dr. Kenneth Bernstein

PROVIDER: MSV000084640 | GNPS | Mon Dec 02 11:30:00 GMT 2019

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Ace Over Expression in Mice Targeted Metabolomics Study

Project description:Over-expression of angiotensin converting enzyme in mouse neutrophils and macrophages producing phenotypic changes in metabolism.

2019-12-02 | MSV000084640 | MassIVE

Penicillium oxalicum

Project description:A lignocellulolytic enzyme-producing fungus

| PRJNA214440 | ENA

Targeted Inhibition of Purine Metabolism is Effective in Suppressing Hepatocellular Carcinoma Progression

Project description:Tumor-specific metabolic rewiring, intended to confer a survival advantage over non-transformed cells, often offers an opportunity to target cancers. Here, we identify deregulated expression of purine biosynthetic enzymes as a metabolic hallmark in human hepatocellular carcinomas (HCC), with the extent of enzyme upregulation a predictor of clinical outcome. We demonstrate in HCC cell lines, patient-derived xenograft (PDX) organoids and mouse models that inhibition of purine biosynthesis abrogated cancer cell proliferation and tumor growth. Mechanistically, a PI3K-E2F1 axis coordinated purine biosynthetic enzyme expression. Clinically approved inhibitors against PI3K and the purine biosynthetic rate-limiting enzyme IMPDH synergistically reduced the tumor burden in a PDX mouse model. Collectively, our results support targeting purine metabolic reprogramming as a precision therapeutic strategy for HCC patients.

2020-07-06 | GSE145988 | GEO

Gene expression profile of the major phenotypic subsets of tissue-resident and tissue disease-associated macrophages from healthy and nephritic NZB/W lupus prone mice respectively in comparison to disease-monocyte transcriptional profile

Project description:We employed bulk RNA-sequencing to compare gene expression between the two major phenotypic subsets of disease-associated macrophages based on MHCII protein expression as well as tissue-resident macrophages and disease-monocytes.

2024-07-11 | GSE269402 | GEO

Gene expression profile of Macrophages Following Helminth Enzyme Exposure Targeting Prostaglandin Synthesis

Project description:Gene expression profile of Macrophages Following Helminth Enzyme Exposure Targeting Prostaglandin Synthesis

| PRJNA1081278 | ENA

Genome-wide anyalysis of gene expression during prolonged endotoxin tolerance in Aoah -/- mice

2012-08-17 | GSE40154 | GEO

Genomic expression over batch growth of mupirocin producing strain Pseudomonas synxantha NCIMB10586

Project description:Genomic expression over batch growth of mupirocin producing strain Pseudomonas synxantha NCIMB10586

| PRJEB43854 | ENA

Increased carvone production in Escherichia coli by balancing limonene conversion enzyme expression via targeted quantification concatamer proteome analysis

Project description:The cytochrome P450 limonene-6-hydroxylase (P450), cytochrome P450 reductase (CPR) and carveol dehydrogenase (CDH) were expressed in Escherichia coli for (−)-carvone production from (−)-limonene. The optimum ratio of enzyme expression to maximize (−)-carvone production was determined using the proteome analysis quantification concatamer (QconCAT) method.

2022-08-24 | PXD028077 | JPOST Repository

Genome-wide anyalysis of gene expression during prolonged endotoxin tolerance in Aoah -/- mice

Project description:Analysis of gene expression in explanted peritoneal macrophages from Aoah -/- and Aoah +/+ mice treated with LPS 21 days prior to harvest. Explanted peritoneal machrophages were challenged with LPS or control (PBS). The study seeks to characterize global gene expression in the state of prolonged LPS tolerance induced in mice lacking the LPS-inactivating enzyme Aoah. Groups of 9 C57BL/6 Aoah+/+ or Aoah-/- mice were given i.p. injections of 10 µg E. coli LPS/mouse. Twenty-one days later (when Aoah-/- mice remain tolerant and Aoah+/+ mice have recovered), peritoneal macrophages were harvested and the yields from three mice were pooled to form 3 samples per group (i.e., three samples of Aoah+/+ and Aoah-/- mice, with each sample comprised of peritoneal macrophages from 3 mice). Next day, cells were challenged with LPS or PBS and whole RNA was isolated 2 hours later and used for microarray experiments.

2012-08-17 | E-GEOD-40154 | biostudies-arrayexpress

Macrophage-targeted Therapy Unlocks Antitumoral Crosstalk Between IFN -secreting Lymphocytes and IL12-producing Dendritic Cells

Project description:Macrophages often abound within tumors, express colony-stimulating factor 1 receptor (CSF1R), and are linked to adverse patient survival. Drugs blocking CSF1R signaling have been used to suppress tumor-promoting macrophage responses; however, their mechanisms of action remain incompletely understood. Here, we assessed the lung tumor immune microenvironment in mice treated with BLZ945, a prototypical small-molecule CSF1R inhibitor, using single-cell RNA sequencing and mechanistic validation approaches. We showed that tumor control was not caused by CSF1R+ cell depletion; instead, CSF1R targeting reshaped the CSF1R+ cell landscape, which unlocked crosstalk between antitumoral CSF1R- cells. These cells included IFN -producing natural killer and T cells, and an IL12-producing dendritic cell subset, denoted as DC3, which were all necessary for CSF1R inhibitor–mediated lung tumor control. These data indicate that CSF1R targeting can activate a cardinal crosstalk between cells that are not macrophages and that are essential to mediate the effects of T cell–targeted immunotherapies and promote antitumor immunity.

2021-12-01 | GSE161771 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data